We are live on ! Find out more
BE

Bonness Enterprises Portfolio holdings

AUM $310M
1-Year Est. Return 24.22%
This Fund
S&P 500
This Quarter Est. Return
+5.61%
1 Year Est. Return
+24.22%
3 Year Est. Return
+94.56%
5 Year Est. Return
+137.52%
10 Year Est. Return
+441.57%
AUM
$199M
AUM Growth
+$11.6M
Cap. Flow
+$1.99M
Cap. Flow %
1%
Top 10 Hldgs %
63.28%
Holding
40
New
1
Increased
3
Reduced
2
Closed

Top Buys

Rank Stock Value
1
GSK icon
GSK
GSK
+$1.21M
2
T icon
AT&T
T
+$485K
3
UL icon
Unilever
UL
+$361K
4
OGN icon
Organon & Co
OGN
+$229K

Top Sells

Rank Stock Value
1
MRK icon
Merck
MRK
+$248K
2
PHG icon
Philips
PHG
+$47K

Sector Composition

Rank Sector Weight
1 Financials 31.62%
2 Healthcare 28.98%
3 Technology 24.27%
4 Industrials 4.38%
5 Consumer Staples 4.22%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PHG icon
26
Philips
PHG
$25.6B
$2.25M 1.13%
54,863
-1,017
-2% -$47K
PG icon
27
Procter & Gamble
PG
$337B
$2.21M 1.11%
16,400
VZ icon
28
Verizon
VZ
$198B
$2.07M 1.04%
36,987
ORCL icon
29
Oracle
ORCL
$404B
$2M 1.01%
25,700
HPQ icon
30
HP
HPQ
$24.9B
$1.72M 0.87%
57,100
KO icon
31
Coca-Cola
KO
$374B
$1.71M 0.86%
31,600
CAJ
32
DELISTED
Canon, Inc.
CAJ
$1.68M 0.85%
74,200
NTRS icon
33
Northern Trust
NTRS
$33.3B
$1.47M 0.74%
12,700
GEN icon
34
Gen Digital
GEN
$16.8B
$1.4M 0.71%
51,500
GE icon
35
GE Aerospace
GE
$382B
$1.4M 0.7%
20,782
ING icon
36
ING
ING
$101B
$1.09M 0.55%
82,000
XOM icon
37
ExxonMobil
XOM
$639B
$895K 0.45%
14,185
HPE icon
38
Hewlett Packard
HPE
$66.3B
$833K 0.42%
57,100
BRK.B icon
39
Berkshire Hathaway Class B
BRK.B
$1.11T
$375K 0.19%
1,350
OGN icon
40
Organon & Co
OGN
$3.56B
$210K 0.11%
+6,950
New +$229K

Similar funds

Bonness Enterprises's Q2 2021 Portfolio in Review

As of Q2 2021, Bonness Enterprises held 40 positions worth $199M, up 6.2% from $187M the previous quarter. Its ten largest holdings account for 63% of the portfolio.

Trading was light in Q2 2021: portfolio turnover was 2.5%. Bonness Enterprises opened 1 new position and made no exits, leaving the 40-position portfolio largely intact.

By sector, the portfolio is most concentrated in Financials at 32% of assets, down from 32% a quarter earlier, followed by Healthcare and Technology.

  • Bonness Enterprises's largest Q2 2021 buy was Organon & Co: 6,950 shares worth $210K.
  • Bonness Enterprises added most to GSK in Q2 2021, an estimated $1.21M increase.
  • Bonness Enterprises's biggest Q2 2021 reduction was Merck, cutting an estimated $248K.
  • Bonness Enterprises's ten largest holdings make up 63% of its $199M portfolio in Q2 2021.
  • Bonness Enterprises opened 1 new position and closed 0 in Q2 2021.
  • Bonness Enterprises's portfolio value rose 6.2% quarter-over-quarter to $199M.

Based on Bonness Enterprises's 13F filing for Q2 2021, filed 13 Jul 2021.